616 related articles for article (PubMed ID: 19370626)
1. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626
[TBL] [Abstract][Full Text] [Related]
2. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Apr; (4):CD006117. PubMed ID: 20393946
[TBL] [Abstract][Full Text] [Related]
3. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Jan; (1):CD006117. PubMed ID: 20091586
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine versus other anti-depressive agents for depression.
Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
6. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
7. Citalopram versus other anti-depressive agents for depression.
Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
[TBL] [Abstract][Full Text] [Related]
8. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
10. Milnacipran versus other antidepressive agents for depression.
Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
[TBL] [Abstract][Full Text] [Related]
11. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
13. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram versus other antidepressive agents for depression.
Cipriani A; Santilli C; Furukawa TA; Signoretti A; Nakagawa A; McGuire H; Churchill R; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006532. PubMed ID: 19370639
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
[TBL] [Abstract][Full Text] [Related]
17. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine versus other antidepressive agents for depression.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine versus other anti-depressive agents for depression.
Omori IM; Watanabe N; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2010 Mar; (3):CD006114. PubMed ID: 20238342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
